静脈内ソリューションの世界市場レポート 2024

静脈内ソリューションの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.9%の年間複合成長率（CAGR）で189億5,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、人口の増加と高齢化、外科手術の増加、感染症の罹患率の上昇、遠隔医療と遠隔患者モニタリングの採用、予防医療への注力、世界的な医療安全保障への投資、患者中心のケアへの傾向などの要因によるものです。予測期間中に予想される主な動向には、非経口栄養輸液の需要増加、プレミックス輸液の採用増加、在宅輸液療法の拡大、電解質バランス輸液の導入、新規薬剤添加剤や補助剤の導入、モニタリング用スマート輸液システムの統合などがあります。

がんの有病率の増加は、将来の静脈内ソリューション市場の成長を促進すると見込まれています。がんは、制御されない細胞増殖と周囲の組織に侵入する能力を特徴としており、化学療法を含むさまざまな治療が必要です。 静脈内ソリューションは、化学療法薬を投与し、治療中の水分補給を維持することにより、がん治療において重要な役割を果たします。たとえば、American Cancer Society Inc.は、2023年に米国で約190万人の新たながん症例が発生すると予測しており、2020年の新たに診断された180万人から増加しています。さらに、2023年には60万9,820人のがん関連死亡が予想されています。したがって、がんの有病率の上昇は、静脈内ソリューション市場の成長の主要な原動力となっています。

外科手術件数の増加も静脈内ソリューション市場の拡大に寄与すると予想されます。切開や侵襲的アプローチを通じてさまざまな疾患や障害を治療するために採用される外科手術では、水分補給、電解質バランス、薬物投与、緊急介入などの重要なサポートを静脈内ソリューションに依存しています。実例として、2023年9月の国際美容形成外科学会のデータによると、2022年には世界中の形成外科医が約1,490万件の外科的処置と1,880万件の非外科的処置を実施し、手術総数が11.2%増加したことが明らかになりました。したがって、外科手術の数の増加が静脈内ソリューション市場の成長を推進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の静脈内ソリューション市場、製品別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 完全非経口栄養学
• 末梢非経口栄養法
• 世界の静脈内ソリューション市場、栄養素別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 炭水化物
• ビタミンとミネラル
• 単回投与アミノ酸
• 非経口脂質エマルジョン
• その他の栄養素
• 世界の静脈内ソリューション市場、用途別のセグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 基本的な静脈内（IV）溶液
• 栄養点滴（IV）液
• 血液点滴（IV）液
• 薬物の静脈内（IV）溶液
• 灌注静脈内（IV）溶液
• 世界の静脈内ソリューション市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院
• クリニック
• 外来手術センター
• 在宅ケア環境

第7章 地域および国の分析

• 世界の静脈内ソリューション市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の点滴ソリューション市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 静脈内ソリューション市場の競合情勢
• 静脈内ソリューション市場の企業プロファイル
  • Pfizer Inc.
  • Abbott Laboratories
  • Eli Lilly and Company
  • Fresenius SE &Co. KGaA
  • Becton, Dickinson and Company

第31章 その他の主要および革新的な企業

• Baxter International Inc.
• Otsuka Pharmaceutical Co. Ltd.
• CSL Limited
• B. Braun Melsungen AG
• Grifols SA
• Terumo Corporation
• Nipro Corporation
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Cipla Limited
• Hikma Pharmaceuticals PLC
• ICU Medical Inc.
• Gland Pharma Limited
• Cisen Pharmaceutical Co. Ltd.
• Amsino International Inc.
• JW Life Science Co. Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Intravenous solutions are sterile liquids administered directly into a patient's bloodstream, primarily for purposes of hydration, medication delivery, or nutrient supplementation. These solutions play a crucial role in intravenous therapy, serving to restore or maintain normal fluid volume and electrolyte balance in situations where oral administration is not feasible.

The main types of products within the category of intravenous solutions include total parenteral nutrition (TPN) and peripheral parenteral nutrition. Total parenteral nutrition is a method employed to provide essential nutrients and fluids directly into the bloodstream for individuals unable to eat or absorb nutrients through the digestive system. Various nutrients, including carbohydrates, vitamins and minerals, single-dose amino acids, parenteral lipid emulsion, among others, are utilized in applications such as basic intravenous (IV) solution, nutritional intravenous (IV) solution, blood intravenous (IV) solution, drug intravenous (IV) solution, and irrigation intravenous (IV) solution. End users of these intravenous solutions include hospitals, clinics, ambulatory surgery centers, and home care settings.

The intravenous solutions market research report is one of a series of new reports from The Business Research Company that provides intravenous solutions market statistics, including intravenous solutions industry global market size, regional shares, competitors with an intravenous solutions market share, detailed intravenous solutions market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous solutions industry. This intravenous solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous solutions market size has grown strongly in recent years. It will grow from $12.9 billion in 2023 to $14 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed in the historical period can be attributed to various factors, including an increase in surgical procedures, a growing prevalence of chronic diseases, the expansion of home healthcare services, stringent regulations ensuring product safety, an increased focus on patient hydration, and global emergency preparedness initiatives.

The intravenous solutions market size is expected to see strong growth in the next few years. It will grow to $18.95 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth in the forecast period can be attributed to factors such as population growth and aging, an increase in surgical interventions, a rising incidence of infectious diseases, the adoption of telemedicine and remote patient monitoring, a focus on preventive healthcare, investments in global health security, and the trends towards patient-centric care. Major trends expected in the forecast period include an increased demand for parenteral nutrition solutions, a rise in the adoption of pre-mixed IV solutions, the expansion of home infusion therapies, the introduction of electrolyte-balanced solutions, the introduction of novel drug additives and adjuncts, and the integration of smart IV systems for monitoring.

The increase in the prevalence of cancer is poised to drive the growth of the intravenous solutions market in the future. Cancer, characterized by uncontrolled cell growth and the ability to invade surrounding tissues, necessitates various treatments, including chemotherapy. Intravenous solutions play a crucial role in cancer treatment by delivering chemotherapy drugs and maintaining hydration during therapy. For example, in 2023, the American Cancer Society Inc. projects approximately 1.9 million new cancer cases in the United States, marking an increase from 1.8 million new cases diagnosed in 2020. Additionally, an anticipated 609,820 cancer-related deaths are expected in 2023, up from 606,520 in 2020. Hence, the rising prevalence of cancer is a key driver for the growth of the intravenous solutions market.

The increasing number of surgical procedures is also expected to contribute to the expansion of the intravenous solutions market. Surgical procedures, employed to treat various diseases and disorders through incisions or invasive approaches, rely on intravenous solutions for essential support, including hydration, electrolyte balance, medication administration, and emergency interventions. As an illustration, data from the International Society of Aesthetic Plastic Surgery in September 2023 revealed that in 2022, plastic surgeons worldwide conducted approximately 14.9 million surgical and 18.8 million non-surgical procedures, indicating an 11.2% increase in total procedures. Therefore, the growing number of surgical procedures is driving the growth of the intravenous solutions market.

The high cost of intravenous solutions is identified as a constraint for the intravenous solutions market, potentially limiting access to care for patients who cannot afford the treatments. The elevated costs may result in decreased demand for these products, as patients and healthcare providers may explore alternative, more affordable treatments. For example, in March 2023, Forbes Health reported that the cost of IV (intravenous) therapy varies across the United States, with customers typically facing an average price range of $200 to $400 per bag, influenced by the specific ingredients chosen. Consequently, the high cost of intravenous solutions poses a restriction on the growth of the intravenous solutions market.

Key companies in the intravenous solutions market are strategically focusing on the development of innovative syringes, such as pre-filled and ready-to-administer syringes, to gain a competitive advantage. Pre-filled and ready-to-administer syringes come preloaded with medication, designed for immediate use without the need for manual filling or preparation. For instance, in August 2023, GENIXUS Corp., a US-based healthcare company, introduced KinetiX Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes. These syringes are made of transparent, durable polymer material, eliminating risks associated with glass syringes. They are pre-filled and ready for administration, saving time and reducing medication errors. The product possesses features such as RFID-enabled technology with KitCheck, intuitive labeling, and a color-coded plunger rod for rapid identification.

In August 2022, CSL Limited, an Australia-based specialty biotechnology company, acquired Vifor Pharma AG for an undisclosed amount. This strategic acquisition enables CSL Limited to diversify its portfolio, expand its product offerings, increase revenue, and access new markets. Vifor Pharma AG, based in Switzerland, is a pharmaceutical manufacturing company providing intravenous (IV) solutions for the treatment of iron deficiency, nephrology, and rare diseases.

Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

North America was the largest region in the intravenous solutions market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intravenous solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intravenous solutions market consists of sales of dextrose 5% in water (D5W), 0.45% sodium chloride (half normal saline), dextrose 5% in normal saline (D5NS), 0.2% sodium chloride (hypotonic saline), and dextrose 10% in water (D10W). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous Solutions Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intravenous solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Total Parenteral Nutrition; Peripheral Parenteral Nutrition
• 2) By Nutrients: Carbohydrates; Vitamins And Minerals; Single Dose Amino Acids; Parenteral Lipid Emulsion; Other Nutrients
• 3) By Application: Basic Intravenous (IV) Solution; Nutritional Intravenous (IV) Solution; Blood Intravenous (IV) Solution; Drug Intravenous (IV) Solution; Irrigation Intravenous (IV) Solution
• 4) By End User: Hospitals; Clinics; Ambulatory Surgery Centers; Home Care Settings
• Companies Mentioned: Pfizer Inc.; Abbott Laboratories; Eli Lilly and Company; Fresenius SE & Co. KGaA; Becton, Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intravenous Solutions Market Characteristics

3. Intravenous Solutions Market Trends And Strategies

4. Intravenous Solutions Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Intravenous Solutions Market Size and Growth

• 5.1. Global Intravenous Solutions Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Intravenous Solutions Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Intravenous Solutions Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Intravenous Solutions Market Segmentation

• 6.1. Global Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition
• 6.2. Global Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Carbohydrates
• Vitamins And Minerals
• Single Dose Amino Acids
• Parenteral Lipid Emulsion
• Other Nutrients
• 6.3. Global Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Basic Intravenous (IV) Solution
• Nutritional Intravenous (IV) Solution
• Blood Intravenous (IV) Solution
• Drug Intravenous (IV) Solution
• Irrigation Intravenous (IV) Solution
• 6.4. Global Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgery Centers
• Home Care Settings

7. Intravenous Solutions Market Regional And Country Analysis

• 7.1. Global Intravenous Solutions Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Intravenous Solutions Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Intravenous Solutions Market

• 8.1. Asia-Pacific Intravenous Solutions Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Intravenous Solutions Market

• 9.1. China Intravenous Solutions Market Overview
• 9.2. China Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Intravenous Solutions Market

• 10.1. India Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Intravenous Solutions Market

• 11.1. Japan Intravenous Solutions Market Overview
• 11.2. Japan Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Intravenous Solutions Market

• 12.1. Australia Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Intravenous Solutions Market

• 13.1. Indonesia Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Intravenous Solutions Market

• 14.1. South Korea Intravenous Solutions Market Overview
• 14.2. South Korea Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Intravenous Solutions Market

• 15.1. Western Europe Intravenous Solutions Market Overview
• 15.2. Western Europe Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Intravenous Solutions Market

• 16.1. UK Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Intravenous Solutions Market

• 17.1. Germany Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Intravenous Solutions Market

• 18.1. France Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Intravenous Solutions Market

• 19.1. Italy Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Intravenous Solutions Market

• 20.1. Spain Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Intravenous Solutions Market

• 21.1. Eastern Europe Intravenous Solutions Market Overview
• 21.2. Eastern Europe Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Intravenous Solutions Market

• 22.1. Russia Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Intravenous Solutions Market

• 23.1. North America Intravenous Solutions Market Overview
• 23.2. North America Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Intravenous Solutions Market

• 24.1. USA Intravenous Solutions Market Overview
• 24.2. USA Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Intravenous Solutions Market

• 25.1. Canada Intravenous Solutions Market Overview
• 25.2. Canada Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Intravenous Solutions Market

• 26.1. South America Intravenous Solutions Market Overview
• 26.2. South America Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Intravenous Solutions Market

• 27.1. Brazil Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Intravenous Solutions Market

• 28.1. Middle East Intravenous Solutions Market Overview
• 28.2. Middle East Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Intravenous Solutions Market

• 29.1. Africa Intravenous Solutions Market Overview
• 29.2. Africa Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Intravenous Solutions Market Competitive Landscape And Company Profiles

• 30.1. Intravenous Solutions Market Competitive Landscape
• 30.2. Intravenous Solutions Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Abbott Laboratories
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Eli Lilly and Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Fresenius SE & Co. KGaA
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Becton, Dickinson and Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Intravenous Solutions Market Other Major And Innovative Companies

• 31.1. Baxter International Inc.
• 31.2. Otsuka Pharmaceutical Co. Ltd.
• 31.3. CSL Limited
• 31.4. B. Braun Melsungen AG
• 31.5. Grifols S.A.
• 31.6. Terumo Corporation
• 31.7. Nipro Corporation
• 31.8. Sichuan Kelun Pharmaceutical Co. Ltd.
• 31.9. Cipla Limited
• 31.10. Hikma Pharmaceuticals PLC
• 31.11. ICU Medical Inc.
• 31.12. Gland Pharma Limited
• 31.13. Cisen Pharmaceutical Co. Ltd.
• 31.14. Amsino International Inc.
• 31.15. JW Life Science Co. Ltd.

32. Global Intravenous Solutions Market Competitive Benchmarking

33. Global Intravenous Solutions Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Intravenous Solutions Market

35. Intravenous Solutions Market Future Outlook and Potential Analysis

• 35.1 Intravenous Solutions Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Intravenous Solutions Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Intravenous Solutions Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer